Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
about
A threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genesIs cognitive functioning impaired in methamphetamine users? A critical reviewMephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatumHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuseMethamphetamine toxicity and messengers of deathPotential adverse effects of amphetamine treatment on brain and behavior: a reviewImpaired time perception and motor timing in stimulant-dependent subjectsMethamphetamine effects on blood-brain barrier structure and functionAn Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future ResearchVesicular integrity in Parkinson's diseasePeripheral blood RNA expression profiling in illicit methcathinone users reveals effect on immune systemThe Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking BehaviourDysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposureNeonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineImaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityMethamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.fMRI of cocaine self-administration in macaques reveals functional inhibition of basal gangliaChanges in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuseBehavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats.Behavioral genetic contributions to the study of addiction-related amphetamine effects.Functional and structural brain changes associated with methamphetamine abuseChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation.White-matter abnormalities in brain during early abstinence from methamphetamine abuse.Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.Parkinsonism in patients with a history of amphetamine exposure.Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performanceMethamphetamine abuse, HIV infection, and neurotoxicity.Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performanceSelective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in miceDisparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.Developmental lead exposure attenuates methamphetamine dose-effect self-administration performance and progressive ratio responding in the male rat.
P2860
Q23914101-ABEE9663-6898-4CA3-96E8-5B7A53E5E42FQ24606455-241E9979-0356-4EF3-BBE6-45A8AFE43718Q24621938-9FF402CA-1D12-4DEA-AD7D-46866D99C65CQ24631675-A210A00F-1027-43F1-B3EE-0D03E57B2A4FQ24634712-FFBD7D8F-72D3-42E4-9A51-A7A724A24A5FQ24647617-D1701291-3327-4BC2-8A74-045C245A9529Q24657966-02C24A94-0D18-4F7D-B04A-179DA2407E37Q24679730-D3A79E9E-161B-44CA-8F6B-9A595227803DQ26825795-AAD5A807-06B8-492E-B1DC-C45C6E5E724EQ26829172-3C4E799A-7588-490E-9FE6-885D62F2D84FQ28385737-78A03AC3-9598-4585-85FF-05E5A5B6241DQ28396147-D2E23286-18E9-4DE5-B20E-3994AE0B45BAQ28547330-09F8F5C0-4657-40AF-BE67-FEA5FD398E32Q28729938-CE69EA07-6A25-450D-A49C-4069A75E9923Q30401457-BDF97FC7-B3DC-440B-B223-849023BE61DCQ30417935-68FDC80E-B317-4ACD-8613-E141DB83AD5AQ30422045-416A43C5-4EEA-4F0A-965E-7CCBF36A6153Q30443801-E8CCDA02-40E3-4B99-85E8-9A337F103EE5Q30473348-E5BEF856-7BE3-4E84-BA42-E9FD8CCE410FQ30484807-9BBC8144-A7E7-43BE-974B-E6C251415D53Q30486638-1F19A219-80D5-45AE-BF10-51139C665A42Q30494693-71175FC0-5C9B-483A-B51F-0049FE4982B0Q30833169-4362E779-14A1-4549-B7E0-E019DA7C18ADQ30873118-0F89C5BF-9609-4E58-B8CE-E52030F64731Q33383360-DC30BAFB-7B6D-4C98-9E60-9E4D0FC9F18CQ33536778-B24D9180-B685-4BDE-801F-7BF060B97916Q33582740-EB2BBFE9-EEDA-468B-813F-5EE6341A5AE9Q33602644-48EA5FFD-D945-4047-BB05-BA80F9C606ABQ33605970-A3B83622-1DAB-42C6-9E9D-62F12E617780Q33643608-8853DF4C-5CE7-4026-A0FA-5456E040DD3DQ33652554-F1A97DE2-2A8D-4EA9-ACE8-F9ACAFB6C8C1Q33698983-12ADC55F-FD91-4EB5-8722-3ADF738B6EECQ33768609-467CAC6F-6A23-431A-9B88-A62DDC7B8246Q33772001-FF6188E9-B551-4647-9F3B-8895D1559ACCQ33799373-EC338A03-57FC-46E8-9E8A-F5282A4AB4ADQ33807300-43326A4A-911E-40D6-AA91-875907E58F03Q33873281-F0C7114E-A862-42B9-9250-41BF69F0485BQ33899756-C8FEBB14-FA06-441E-A360-B6BD31A3EF91Q33915570-BB573DF1-E459-4D41-8ACE-B03A5E87C5B4Q33956985-F5AA841F-3BF6-4542-8522-EB8F0BF4A6BD
P2860
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Reduced striatal dopamine tran ...... studies with [11C]WIN-35,428.
@en
Reduced striatal dopamine tran ...... studies with [11C]WIN-35,428.
@nl
type
label
Reduced striatal dopamine tran ...... studies with [11C]WIN-35,428.
@en
Reduced striatal dopamine tran ...... studies with [11C]WIN-35,428.
@nl
prefLabel
Reduced striatal dopamine tran ...... studies with [11C]WIN-35,428.
@en
Reduced striatal dopamine tran ...... studies with [11C]WIN-35,428.
@nl
P2093
P1476
Reduced striatal dopamine tran ...... y studies with [11C]WIN-35,428
@en
P2093
G A Ricaurte
R F Dannals
U D McCann
V Villemagne
P304
P356
10.1523/JNEUROSCI.18-20-08417.1998
P407
P577
1998-10-01T00:00:00Z